CORONA Remedies Ltd. (CORONA): CORONA Remedies Share Price hits fresh 52-week high on 15 September 2026

CORONA Remedies Share Price was at Rs 2,255.40, up 0.85% from the previous close, after touching a fresh 52-week high of Rs 2,285. The company’s market capitalisation stood at Rs 13,677.23 Cr as the stock stayed in focus in today’s stock news. According to latest Univest data, the move confirms the 52-week high event, but it does not establish a company-specific catalyst. For investors tracking CORONA Remedies Share Price Today, the key question is how the current price, valuation and sector comparison fit together in the latest market update.

The stock opened at Rs 2,236 and moved between Rs 2,197.90 and Rs 2,285 during the morning session. The latest Univest figures also show turnover of Rs 0.93 Cr. CORONA Remedies Share Price is now being watched for how it behaves around the yearly high, while Univest data also places the stock’s valuation and operating metrics in the broader healthcare context.

CORONA Remedies Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,255.4
Previous Close	Rs 2,236.3
Today's Move	+Rs 19.1 (+0.85%)
Open	Rs 2,236
High	Rs 2,285
Low	Rs 2,197.9
Turnover	Rs 0.93 crore
Market Capitalisation	Rs 13,677.23 crore

CORONA Remedies Ltd. (CORONA) traded at Rs 2,255.4 versus the previous close of Rs 2,236.3, a rise of 0.85%. The stock opened at Rs 2,236, reached a high of Rs 2,285 and touched a low of Rs 2,197.9.

CORONA Remedies Share Price Today reflected a gain of Rs 19.10 from the previous close of Rs 2,236.30, with the stock last traded at Rs 2,255.40. The day open was Rs 2,236, and the price range stretched from Rs 2,197.90 to Rs 2,285, which is also the fresh 52-week high. On the current reading, the stock is trading Rs 29.60 below that peak after first touching it intraday. Turnover stood at Rs 0.93 Cr, and the latest Univest data confirms the event without assigning a cause. For readers following CORONA Remedies Share Price News, this is the main price development to note today.

Since the previous 52-week high was not supplied, no breakout percentage is calculated here. What matters for CORONA Remedies Share Price is that the stock has already reached a one-year high while still trading within the same morning range. That keeps CORONA Remedies Share Price in the stock news flow on Univest and in broader share market today searches.

CORONA Remedies Ltd. (CORONA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 13,677.23 crore
P/E Ratio	68.72x
P/B Ratio	16.95x
ROE	27.36%
ROCE	31.74%
EPS	Rs 32.54
Book Value Per Share	Rs 131.94
Dividend Yield	0.45%

CORONA Remedies Ltd. (CORONA) fundamental metrics show P/E 68.72x, P/B 16.95x, ROE 27.36%, ROCE 31.74%. These figures provide context only and are not a buy or sell signal.

CORONA Remedies Ltd. has a market capitalisation of Rs 13677.23 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 68.72x, P/B at 16.95x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.36% and ROCE of 31.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 32.54, book value per share of Rs 131.94, dividend yield of 0.45%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.41x, median ROE of 11.61%, median ROCE of 13.18%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	68.72x
Benchmark Median P/E	32.41x
Benchmark Average P/E	49.04x
Benchmark P/E Range	3.34x to 693.7x
Company P/B Ratio	16.95x
Benchmark Median P/B	3.04x
Company ROE	27.36%
Benchmark Median ROE	11.61%
Company ROCE	31.74%
Benchmark Median ROCE	13.18%
Company Market Capitalisation	Rs 13,677.23 crore
Benchmark Median Market Cap	Rs 692.38 crore

CORONA Remedies Ltd. (CORONA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

CORONA Remedies Ltd. (CORONA) has a P/E ratio of 68.72x, which is above the benchmark median of 32.41x, a difference of +112.03%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

CORONA Remedies Ltd. (CORONA) has a ROE of 27.36%, which is above the benchmark median of 11.61%, a difference of +135.66%. CORONA Remedies Ltd. (CORONA) has a ROCE of 31.74%, which is above the benchmark median of 13.18%, a difference of +140.82%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sudeep Pharma Ltd.	SUDEEPPHRM	13,560.61	74.25	14.68	25.37	28.5
Natco Pharma Ltd.	NATCOPHARM	14,599.25	12.76	1.56	16.3	17.16
Marksans Pharma Ltd.	MARKSANS	14,877.37	28.79	4.68	15.31	21.1
Akums Drugs & Pharmaceuticals Ltd.	AKUMS	12,216.92	41.88	3.58	8.06	14.77
Concord Biotech Ltd.	CONCORDBIO	15,762	57.24	7.6	13.54	18.04

CORONA Remedies Ltd. (CORONA) has a P/E ratio of 68.72x compared with the displayed peer median of 41.88x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 27.36% compares with a peer median of 15.31% across the companies shown in the table. ROCE stood at 31.74% versus the displayed peer median of 18.04%, providing a capital-efficiency comparison. CORONA Remedies Ltd. (CORONA) has a market capitalisation of Rs 13,677.23 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching CORONA Remedies

• CORONA Remedies Share Price touched a fresh 52-week high of Rs 2,285 during the morning session.
• CORONA Remedies Share Price Today was last traded at Rs 2,255.40, up Rs 19.10 from the previous close.
• Market capitalisation stood at Rs 13,677.23 Cr in the latest Univest figures.
• P/E at 68.72 and P/B at 16.95 are both above the healthcare industry median.
• ROE of 27.36% and ROCE of 31.74% are above the industry medians in the same industry benchmark.

About CORONA Remedies

CORONA Remedies Ltd. operates in the healthcare sector and the pharmaceuticals & drugs industry. CORONA Remedies Share Price is therefore read alongside a business profile that sits within one of India’s most closely tracked healthcare market groups. For Univest readers, CORONA Remedies Stock News today is mainly tied to the fresh 52-week high and the company’s valuation and return ratios.

Frequently Asked Questions

What is CORONA Remedies Share Price today?

Ans. CORONA Remedies Share Price was last traded at Rs 2,255.40, up 0.85% from the previous close of Rs 2,236.30. The stock also touched a fresh 52-week high of Rs 2,285 in the morning session.

Did CORONA Remedies Share Price hit a fresh 52-week high?

Ans. Yes. CORONA Remedies Share Price touched Rs 2,285, which is the fresh 52-week high for the session. The current price remained below that peak at Rs 2,255.40 when last updated.

What is the market capitalisation of CORONA Remedies?

Ans. CORONA Remedies had a market capitalisation of Rs 13,677.23 Cr. This places CORONA Remedies Share Price within the larger healthcare market-cap bracket tracked in the latest Univest data.

How does CORONA Remedies compare with the healthcare industry valuation?

Ans. CORONA Remedies Share Price trades at a P/E of 68.72 and P/B of 16.95, both above the industry median. That makes the valuation richer than the same-industry benchmark of 203 companies.

What do ROE and ROCE show for CORONA Remedies?

Ans. CORONA Remedies reported ROE of 27.36% and ROCE of 31.74%. Both are above the healthcare industry medians, which gives CORONA Remedies Share Price a stronger return-ratio profile than many peers.

What earnings and book value figures are reported?

Ans. The latest figures show EPS of 32.54 and book value of Rs 131.94. Those numbers help frame CORONA Remedies Share Price alongside the company’s valuation and return ratios.

Is dividend yield part of the CORONA Remedies profile?

Ans. Yes. CORONA Remedies Share Price data includes a dividend yield of 0.45%. It is a factual current measure and should be read together with valuation, EPS and book value.

Where can investors track CORONA Remedies Share Price on Univest?

Ans. Investors can track CORONA Remedies Share Price on Univest for live price updates, 52-week levels, valuation ratios, company financials, sector context and the latest stock news in one place.

Track CORONA Remedies Share Price on Univest

Use CORONA Remedies Ltd. (CORONA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track CORONA Remedies Share Price Live on Univest for the latest share price update, 52-week high level, market capitalisation, company financials, valuation ratios, sector analysis and other market insights. Univest also helps users follow CORONA Remedies Share Price Today, CORONA Remedies Latest News and CORONA Remedies Fundamental Analysis in one place.